Carbohydrate fatty acid monosulphate
Carbohydrate fatty acid monosulphate has been studied in 1 paper since 2021: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Sep 9, 2021: “An adjuvanted SARS-CoV-2 RBD nanoparticle elicits neutralizing antibodies and fully protective immunity in aged mice”.
1 paper studies it2 findingsUpdated
See all 1 papers on carbohydrate fatty acid monosulphate
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Funders: Daiichi Sankyo Europe and 8 more
- 2 of 2 findings with company ties
- Animals1
What did studies of carbohydrate fatty acid monosulphate find?
2Studies of carbohydrate fatty acid monosulphate measured 2 outcomes: type I interferon signaling and antigen retention.
Type I interferon signaling
upin mice1
1 study
Type I interferon signaling
upin mice1
Carbohydrate fatty acid monosulphate activates type I interferon signaling in mice.
“CMS induced antigen retention in the draining lymph node (dLN) and expression of cytokines, chemokines and type I interferon-stimulated genes at both injection site and dLN”
Animalsinjection site and dLN
bioRxiv (Cold Spring Harbor Laboratory)Preprint
Antigen retention
upin mice1
1 study
Antigen retention
upin mice1
Carbohydrate fatty acid monosulphate induces antigen retention in mice.
“CMS induced antigen retention in the draining lymph node (dLN)”
Animalsdraining lymph node
bioRxiv (Cold Spring Harbor Laboratory)Preprint